Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

NCT06071429 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Limb-Threatening Ischemia

Interventions

DEVICE: MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
DEVICE: Percutaneous Transluminal Angioplasty (PTA)

Sponsor

R3 Vascular Inc.